// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Practice Pattern Differences in Generations of Canadian Ophthalmologists over Two Decades

Tina Felfeli - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Can Eyemasks Reduce Neonatal Stress Following Dilated Retinal Examination?

Andrei Szigiato - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Searching for a structural abnormality supportive of the functional anomaly observed in pediatric patients with hydroxychloroquine associated retinal toxicity.

Andre N Ali-Ridha - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Portable OCT retinal evaluation of children undergoing vigabatrin treatment

Xiang Ji - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Vigabatrin

Visually disabled in the Ontario Disability Support Program: Trends in socio-demographics, financial support and use of vision care benefits from 2003 to 2013

Yaping Jin - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Knowledge, beliefs, and attitudes regarding major eye diseases. Comparison between Canadian and Mexican millennials.

Luz America Paczka-Giorgi - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Age-related eye disease and cognitive function

Melanie Varin - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Dissecting the Role of the Premelanosome Protein Gene (PMEL) in the Development of Pigmentary Glaucoma Using the Zebrafish Animal Model

Kim Nguyen-Phuoc - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Targeted next generation amplicon sequencing for candidate genes of Pigment Dispersion Syndrome and Pigmentary Glaucoma

Tim Footz - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Caffeine and Optic Nerve Blood Oxygenation

Vasile Diaconu - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Caffeine

Topical Ocular Anesthesia Has no Effect on Photophobia Induced by Red and Blue Light Stimulus

Shaobo Lei - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

proparacaine HCl

Can we assess the visual function in a blink?

Anthony Fanous - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Photopic Negative Response as an Objective Outcome Measure in Mitochondrial Disease

Melanie R Lalonde - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Cetirizine dihydrochloride - pseudoephedrine hydrochloride

Bringing light to bipolar disorder: peering through the window to the brain

Allison L. Dorfman - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Evaluation of scotopic and photopic function using a mydriasis-free, portable system for recording electroretinograms

Henry Liu - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of the uniform field and pattern ERG in humans

Stuart G Coupland - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Spatial distribution of preserved autofluorescence in patients with choroideremia

Amir H Hariri - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Factors Predicting a Greater Likelihood of Poor Visual Field Reliability in Glaucoma Patients and Suspects

Inas F Aboobakar - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

R-SNARE VAMP7 in rhodopsin trafficking and phototransduction membrane renewal

Dusanka Deretic - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in corneal mechanical, chemical and cold thresholds following repeated tear film instability

Deborah Antwi - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved